


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.89%
-4.24%
-0.77%
ITRI
Itron
$99.47
Strengths

Earnings are forecast to grow

Expands stock buyback program
Risk Analysis

Investors losing their confidence
Chart
$131.33 (-24.26%)
$123.41 (-19.40%)
$131.25 (-24.21%)
$119.29 (-16.61%)
ITRI has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

ITRI overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program

Investors losing their confidence
Future
Future

Earnings are forecast to grow
![]()
ITRI Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ITRI Street Sentiment is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ITRI current stock price?
What are ITRI stock strengths?
What risks are associated with ITRI stock?
When is ITRI next earnings report?
What is ITRI market cap and volume?
What is ITRI's current Stock IQ?
Should I buy ITRI stock right now?
Is ITRI a Strong Buy right now?
What does a 'Strong Buy' rating mean for ITRI?
What does a 'Strong Sell' rating mean for ITRI?
What factors influence ITRI's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.89%
-4.24%
-0.77%
ITRI
Itron
Current Price
$99.47
Stock Insights
Strengths

Earnings are forecast to grow

Expands stock buyback program
Risk Analysis

Investors losing their confidence

Chart
$131.33 (-24.26%)
$123.41 (-19.40%)
$131.25 (-24.21%)
$119.29 (-16.61%)
ITRI Analysts Opinion
ITRI Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program

Investors losing their confidence
Future
Future

Earnings are forecast to grow
![]()
ITRI Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ITRI Street Sentiment is bullish and have positive views on the near-term outlook
ITRI has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
ITRI Latest Analysis
Neuberg Diagnostics said to eye $350 million India IPO in 2026 . Neuberg Diagnostics is reportedly planning a $350 million IPO next year joining Indias booming stock market. Founder GSK Velu also intends to list Trivitron Healthcare and Maxivision Eye Hospitals later. This move aligns with strong growth projections for Indias diagnostics sector driven by increasing chronic diseases and investor appetite.
Tue Nov 11, 2025
LNTH: Can AD Franchise Offset Pylarify Drag?. By Lantheus Holdings Inc. (NASDAQ:LNTH) reported third quarter 2025 financial and operational results on November 6th producing sales of $384 million a 1% increase compared to 3Q:24 levels. Pylarify and Strategic Partnerships saw a year over year decline which was offset by an increase in revenue from Definity TechneLite and Other Precision Diagnostics sales. NeuraCeq revenues were recognized for the first time in 3Q:25 adding $20 million in sales. F
Mon Nov 10, 2025
Why Itron (ITRI) is a Top Growth Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Fri Nov 7, 2025
Why Itron (ITRI) is a Top Value Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Tue Nov 4, 2025
Itron plunges 27% in two days after earnings Baird downgrade as visibility worsens.
Fri Oct 31, 2025
Itron is Now Oversold (ITRI). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Fri Oct 31, 2025
This Itron Analyst Is No Longer ish. Here Are Top 5 Downgrades For Friday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analyst ratings page.RBC Capital analyst Leonid Timashev downgraded ) from Outperform to Sector Perform and lowered the price target from $27 to $11. Bicycle Therapeutics shares closed at $8.76 on Thursday. See how other analysts view this stock.K
Fri Oct 31, 2025
Itron Q3 Earnings & Sales Beat Estimates Decrease Y/Y Stock Down. ITRIs Q3 earnings beat estimates but fall year over year as portfolio shifts and project timing hit revenue.
Fri Oct 31, 2025
Noteworthy Thursday Option Activity: ITRI APLS SHAK. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Itron Inc (Symbol: ITRI) where a total volume of 3790 contracts has been traded thus far today a contract volume which is representative of approximately 379
Thu Oct 30, 2025
Itron (ITRI) Shares Cross Below 200 DMA. In trading on Thursday shares of Itron Inc (Symbol: ITRI) crossed below their 200 day moving average of $117.11 changing hands as low as $107.29 per share. Itron Inc shares are currently trading off about 21.1% on the day. The chart below shows the one year performance of IT
Thu Oct 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ITRI Stock trends
ITRI Stock performance
ITRI Stock analysis
ITRI investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.